docetaxel anhydrous has been researched along with Neuroectodermal Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobilev, D; Ditzler, S; Eslamy, H; Girard, E; Lee, D; Olson, J; Park, J; Richards, A; Vrignaud, P; Yagle, K | 1 |
| Morales, C; Vaquero, J; Zurita, M | 1 |
2 other study(ies) available for docetaxel anhydrous and Neuroectodermal Tumors
| Article | Year |
|---|---|
Efficacy of cabazitaxel in mouse models of pediatric brain tumors.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Disease Models, Animal; Docetaxel; Drug Evaluation, Preclinical; Female; Humans; Male; Maximum Tolerated Dose; Medulloblastoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neuroectodermal Tumors; Rhabdoid Tumor; Survival Analysis; Taxoids; Teratoma; Treatment Outcome; Xenograft Model Antitumor Assays | 2015 |
Growth-inhibiting effects of intralesional docetaxel and paclitaxel on an experimental model of malignant neuroectodermal tumor.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Division; Docetaxel; Ethylnitrosourea; Immunoenzyme Techniques; Injections, Intralesional; Models, Animal; Neoplasms, Experimental; Neuroectodermal Tumors; Paclitaxel; Rats; Rats, Wistar; Taxoids; Time Factors | 2002 |